title: Toxicology and humoral immunity assessment of octamethylcyclotetrasiloxane (D4) following a 28-day whole body vapor inhalation exposure in Fischer 344 rats.
abstract: Octamethylcyclotetrasiloxane, D4, is a low viscosity, silicone fluid consisting of four dimethyl-siloxy units ((CH3)2SiO)4 in a cyclic structure. It is primarily used as a building block in the industrial synthesis of long chain silicone polymers. The combination of D4 with decamethylcyclopentasiloxane (D5) is commonly referred to as cyclomethicone which has a wide range of applications as a formulation aid in personal care products. To extend the existing database regarding the biological activities of D4, a 28 day whole body vapor inhalation study was conducted using Fischer 344 rats at 0 (room air), 7, 20, 60, 180 and 540 ppm for 6 hours/day, 5 days/week. Parameters measured included body weights, organ weights, gross pathology, histopathology, serum chemistries, and urinalysis. In addition to these standard toxicological endpoints, the ability of D4 exposed animals to mount an IgM antibody response was evaluated by a splenic antibody forming cell (AFC) assay and a serum enzyme-linked immunosorbant assay (ELISA). The results of this 28-day inhalation study indicate that D4 exposure caused no adverse effects on body weight, food consumption, or urinalysis parameters. In addition, there were no exposure related histopathological alterations at any site for any exposure group. A statistically significant increase in liver weight and the liver to body weight ratio was observed in both male (180-540 ppm) and female (20-540 ppm) rats, which was not observed in the 14-day recovery group animals. There were no other significant organ weight changes. Although statistically significant changes were observed in several hematological and serum chemistry parameters in both the terminal and 14-day recovery animals, the changes were marginal and within the normal range of values for the rat. Under these experimental conditions, there were no alterations noted in immune system function at any of the D4 exposure levels.
authors.affiliation: Dow Corning Corporation, Midland, MI 48686, USA.
authors.forename: P C
authors.initials: PC
authors.lastname: Klykken
authors.forename: T W
authors.initials: TW
authors.lastname: Galbraith
authors.forename: G B
authors.initials: GB
authors.lastname: Kolesar
authors.forename: P A
authors.initials: PA
authors.lastname: Jean
authors.forename: M R
authors.initials: MR
authors.lastname: Woolhiser
authors.forename: M R
authors.initials: MR
authors.lastname: Elwell
authors.forename: L A
authors.initials: LA
authors.lastname: Burns-Naas
authors.forename: R W
authors.initials: RW
authors.lastname: Mast
authors.forename: J A
authors.initials: JA
authors.lastname: McCay
authors.forename: K L
authors.initials: KL
authors.lastname: White
authors.forename: A E
authors.initials: AE
authors.lastname: Munson
mesh_terms: D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000633:toxicity*; D000280:Administration, Inhalation; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000187:drug effects*; D001772:Blood Cell Count / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D007107:Immune System / Q000187:drug effects*; D007075:Immunoglobulin M / Q000032:analysis; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008297:Male; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011916:Rats, Inbred F344; D012833:Siloxanes / Q000737:chemistry / Q000633:toxicity*; D013154:Spleen / Q000187:drug effects / Q000276:immunology; D018675:Toxicity Tests
chemical_list: D000276:Adjuvants, Immunologic; D007075:Immunoglobulin M; D012833:Siloxanes; C024064:octamethylcyclotetrasiloxane